Indispensability of Pelvic and Paraaortic Lymphadenectomy in Endometrial Cancers

The purposes of this study were to analyze the relationship between retroperitoneal lymph node (RLN) metastasis and clinical and pathologic risk factors in endometrial cancers, and to clarify the correlation between RLN metastasis and survival of patients with the disease. This analysis included 63...

Full description

Saved in:
Bibliographic Details
Published inGynecologic oncology Vol. 64; no. 3; pp. 411 - 417
Main Authors Yokoyama, Yoshihito, Maruyama, Hidetoshi, Sato, Shigemi, Saito, Yoshiharu
Format Journal Article
LanguageEnglish
Published San Diego, CA Elsevier Inc 01.03.1997
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The purposes of this study were to analyze the relationship between retroperitoneal lymph node (RLN) metastasis and clinical and pathologic risk factors in endometrial cancers, and to clarify the correlation between RLN metastasis and survival of patients with the disease. This analysis included 63 patients with endometrial cancer who underwent simultaneous pelvic lymph node (PLN) and paraaortic lymph node (PAN) dissection between April 1988 and December 1995. Patients with stage Ia grade 1 and stage IV disease were excluded from this analysis. Both PLN and PAN metastases were found in 10.0% (4/40) of patients with stage I (FIGO, 1988) disease. Of 14 cases with PLN metastases, 8 (57.1%) had PAN metastases simultaneously, whereas 4 (8.2%) of 49 cases without PLN metastases had PAN metastases. There was no significant relationship between the sites or numbers of positive PLN and PAN metastases. Multivariate analysis revealed that poor grade and deep myometrial invasion had an independent relationship with PAN metastases, whereas vascular space invasion and cervical invasion were independently associated with PLN metastases. When divided into the groups of stage I–II and stage III, the prognosis of patients with RLN metastases was significantly poorer than that of patients without RLN metastases in each stage. Furthermore, survival of patients with PAN metastases was significantly worse compared with that of patients with only PLN metastases (44.4 and 80.0%, respectively,P< 0.05). These results reveal that PLN and PAN metastases occur frequently even in early-stage endometrial cancer, and that RLN metastases, especially PAN metastases, have a serious impact on patient survival. In conclusion, systemically simultaneous pelvic and paraaortic lymphadenectomy is essential for all the patients with endometrial cancer except those with stage Ia grade 1 and stage IV to provide prognostic information and select suitable postoperative treatment as well as to perform accurate FIGO staging, provided the condition of the patient permits.
AbstractList The purposes of this study were to analyze the relationship between retroperitoneal lymph node (RLN) metastasis and clinical and pathologic risk factors in endometrial cancers, and to clarify the correlation between RLN metastasis and survival of patients with the disease. This analysis included 63 patients with endometrial cancer who underwent simultaneous pelvic lymph node (PLN) and paraaortic lymph node (PAN) dissection between April 1988 and December 1995. Patients with stage Ia grade 1 and stage IV disease were excluded from this analysis. Both PLN and PAN metastases were found in 10.0% (4/40) of patients with stage I (FIGO, 1988) disease. Of 14 cases with PLN metastases, 8 (57.1%) had PAN metastases simultaneously, whereas 4 (8.2%) of 49 cases without PLN metastases had PAN metastases. There was no significant relationship between the sites or numbers of positive PLN and PAN metastases. Multivariate analysis revealed that poor grade and deep myometrial invasion had an independent relationship with PAN metastases, whereas vascular space invasion and cervical invasion were independently associated with PLN metastases. When divided into the groups of stage I-II and stage III, the prognosis of patients with RLN metastases was significantly poorer than that of patients without RLN metastases in each stage. Furthermore, survival of patients with PAN metastases was significantly worse compared with that of patients with only PLN metastases (44.4 and 80.0%, respectively, P < 0.05). These results reveal that PLN and PAN metastases occur frequently even in early-stage endometrial cancer, and that RLN metastases, especially PAN metastases, have a serious impact on patient survival. In conclusion, systemically simultaneous pelvic and paraaortic lymphadenectomy is essential for all the patients with endometrial cancer except those with stage Ia grade 1 and stage IV to provide prognostic information and select suitable postoperative treatment as well as to perform accurate FIGO staging, provided the condition of the patient permits.
The purposes of this study were to analyze the relationship between retroperitoneal lymph node (RLN) metastasis and clinical and pathologic risk factors in endometrial cancers, and to clarify the correlation between RLN metastasis and survival of patients with the disease. This analysis included 63 patients with endometrial cancer who underwent simultaneous pelvic lymph node (PLN) and paraaortic lymph node (PAN) dissection between April 1988 and December 1995. Patients with stage Ia grade 1 and stage IV disease were excluded from this analysis. Both PLN and PAN metastases were found in 10.0% (4/40) of patients with stage I (FIGO, 1988) disease. Of 14 cases with PLN metastases, 8 (57.1%) had PAN metastases simultaneously, whereas 4 (8.2%) of 49 cases without PLN metastases had PAN metastases. There was no significant relationship between the sites or numbers of positive PLN and PAN metastases. Multivariate analysis revealed that poor grade and deep myometrial invasion had an independent relationship with PAN metastases, whereas vascular space invasion and cervical invasion were independently associated with PLN metastases. When divided into the groups of stage I-II and stage III, the prognosis of patients with RLN metastases was significantly poorer than that of patients without RLN metastases in each stage. Furthermore, survival of patients with PAN metastases was significantly worse compared with that of patients with only PLN metastases (44.4 and 80.0%, respectively, P &lt; 0.05). These results reveal that PLN and PAN metastases occur frequently even in early-stage endometrial cancer, and that RLN metastases, especially PAN metastases, have a serious impact on patient survival. In conclusion, systemically simultaneous pelvic and paraaortic lymphadenectomy is essential for all the patients with endometrial cancer except those with stage Ia grade 1 and stage IV to provide prognostic information and select suitable postoperative treatment as well as to perform accurate FIGO staging, provided the condition of the patient permits.
Author Sato, Shigemi
Saito, Yoshiharu
Yokoyama, Yoshihito
Maruyama, Hidetoshi
Author_xml – sequence: 1
  givenname: Yoshihito
  surname: Yokoyama
  fullname: Yokoyama, Yoshihito
– sequence: 2
  givenname: Hidetoshi
  surname: Maruyama
  fullname: Maruyama, Hidetoshi
– sequence: 3
  givenname: Shigemi
  surname: Sato
  fullname: Sato, Shigemi
– sequence: 4
  givenname: Yoshiharu
  surname: Saito
  fullname: Saito, Yoshiharu
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2606628$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/9062142$$D View this record in MEDLINE/PubMed
BookMark eNp1kE1r3DAQhkVISTcf194KPpTevB3Zliwdy5K2gYXuoT2LsT5SFVvaSt6A_31kdsmtp2F4nxlmnltyHWKwhHygsKUA_MvzEuKWSsm3HevbK7KhIFnNBZPXZAMgoRYNE-_Jbc5_AaAF2tyQGwm8oV2zIYenYHw-2pBx8KOflyq66mDHF68rDKY6YEKMaS7tfpmOf9DYYPUcp6XyoXoMJk52Th7HaodB25TvyTuHY7YPl3pHfn97_LX7Ue9_fn_afd3Xumu7uW5b6SR1UgzItTC9bhugwBkaJxwbWkZFhxK0M6AF1Y2zPR9KQtmAnUDa3pHP573HFP-dbJ7V5LO244jBxlNWvRB917MV3J5BnWLOyTp1TH7CtCgKalWoVoVqVahWhWXg42XzaZisecMvzkr-6ZJj1ji6VB73-Q1rOHDeiIKJM2aLhRdvk8ra2-LI-FQMKhP9_y54BbCij2s
CODEN GYNOA3
CitedBy_id crossref_primary_10_1111_j_1525_1438_2003_13320_x
crossref_primary_10_1016_j_ijgo_2007_03_035
crossref_primary_10_1097_IGC_0000000000000154
crossref_primary_10_3802_jgo_2010_21_4_209
crossref_primary_10_1097_IGC_0b013e3182094e09
crossref_primary_10_1016_j_gmit_2016_01_003
crossref_primary_10_1016_j_ygyno_2003_11_032
crossref_primary_10_1007_s12253_014_9893_4
crossref_primary_10_1007_s40134_014_0070_z
crossref_primary_10_1016_j_suronc_2008_04_001
crossref_primary_10_1038_sj_bjc_6600468
crossref_primary_10_1111_aogs_12048
crossref_primary_10_1097_CCO_0b013e32833b9b75
crossref_primary_10_1016_j_ygyno_2012_10_008
crossref_primary_10_1016_S0304_3835_01_00803_5
crossref_primary_10_1155_2014_497478
crossref_primary_10_1016_j_ejso_2006_09_035
crossref_primary_10_1016_j_ygyno_2008_01_023
crossref_primary_10_1006_gyno_2000_6111
crossref_primary_10_3892_ol_2014_2653
crossref_primary_10_1016_j_addr_2009_04_015
crossref_primary_10_1093_jjco_28_11_673
crossref_primary_10_3802_jgo_2008_19_4_209
crossref_primary_10_1016_j_ygyno_2017_09_014
crossref_primary_10_3109_00016340903370114
crossref_primary_10_1016_j_ygyno_2004_07_025
crossref_primary_10_1016_j_ygyno_2009_03_032
crossref_primary_10_1097_IGC_0000000000001151
crossref_primary_10_1016_j_ygyno_2010_06_018
crossref_primary_10_1007_s00404_014_3330_5
crossref_primary_10_1016_j_ygyno_2010_12_001
crossref_primary_10_1155_2010_490219
crossref_primary_10_1016_j_ejogrb_2011_04_031
crossref_primary_10_1007_s00404_004_0668_0
crossref_primary_10_1007_s12253_012_9573_1
crossref_primary_10_1016_S0304_5013_06_72581_X
crossref_primary_10_1080_01443615_2017_1281894
crossref_primary_10_1006_gyno_2000_6069
crossref_primary_10_1016_j_ygyno_2011_01_019
crossref_primary_10_1111_j_1525_1438_2006_00534_x
crossref_primary_10_1002_jso_20479
crossref_primary_10_1016_j_tjog_2018_06_012
crossref_primary_10_3390_jcm10081746
crossref_primary_10_1148_radiology_212_3_r99au29711
crossref_primary_10_1111_jog_14953
crossref_primary_10_1006_gyno_1997_4929
crossref_primary_10_1007_s00761_008_1392_3
crossref_primary_10_1097_IGC_0b013e31821a3665
crossref_primary_10_1016_j_ygyno_2015_04_008
crossref_primary_10_1016_S0090_8258_03_00419_0
crossref_primary_10_1111_IGC_0b013e3181a7a2d9
crossref_primary_10_1177_1660_18154
crossref_primary_10_3802_jgo_2017_28_e59
crossref_primary_10_1245_s10434_010_1206_x
crossref_primary_10_1006_gyno_2000_5802
crossref_primary_10_1007_s00404_016_4181_z
crossref_primary_10_1586_era_12_157
crossref_primary_10_5180_jsgoe_31_417
crossref_primary_10_1053_ctrv_2000_0195
crossref_primary_10_1007_s10434_001_0723_z
crossref_primary_10_1016_j_ygyno_2016_01_024
crossref_primary_10_1016_S1074_3804_05_60123_5
crossref_primary_10_1684_bdc_2009_0956
crossref_primary_10_1016_j_gmit_2016_04_001
crossref_primary_10_1016_j_ygyno_2010_05_004
crossref_primary_10_1007_s13224_012_0317_7
crossref_primary_10_1097_IGC_0b013e318249472d
crossref_primary_10_1111_j_1525_1438_2006_00529_x
crossref_primary_10_1016_j_ygyno_2010_11_026
crossref_primary_10_1016_S1470_2045_11_70070_5
crossref_primary_10_1016_j_bpobgyn_2015_02_007
crossref_primary_10_1016_S0140_6736_09_62002_X
crossref_primary_10_1093_jjco_hyl066
crossref_primary_10_1097_RLU_0000000000001414
crossref_primary_10_1097_IGC_0000000000000120
crossref_primary_10_1007_s13193_014_0303_x
crossref_primary_10_1016_j_tjog_2013_01_003
crossref_primary_10_1016_j_pog_2012_06_011
crossref_primary_10_1016_j_ygyno_2012_08_026
crossref_primary_10_1016_j_gyobfe_2010_08_016
crossref_primary_10_7863_jum_2007_26_7_949
crossref_primary_10_32322_jhsm_1208766
crossref_primary_10_1016_S0304_5013_07_73238_7
crossref_primary_10_1080_01443610410001660087
crossref_primary_10_1097_00001703_199802000_00005
crossref_primary_10_1097_GCO_0b013e32831ac3ac
crossref_primary_10_1245_s10434_010_1472_7
crossref_primary_10_1245_s10434_018_6694_0
crossref_primary_10_1007_s00129_006_1929_8
crossref_primary_10_1046_j_1525_1438_2003_13023_x
ContentType Journal Article
Copyright 1997 Academic Press
1997 INIST-CNRS
Copyright_xml – notice: 1997 Academic Press
– notice: 1997 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1006/gyno.1996.4573
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1095-6859
EndPage 417
ExternalDocumentID 10_1006_gyno_1996_4573
9062142
2606628
S0090825896945734
Genre Journal Article
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29I
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQQT
AAQXK
AAXUO
ABBQC
ABFNM
ABFRF
ABJNI
ABLVK
ABMAC
ABMZM
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACRLP
ADBBV
ADEZE
ADFGL
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AEVXI
AFCTW
AFFNX
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AHPSJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
COF
CS3
DM4
DU5
EBS
EFBJH
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HED
HMK
HMO
HVGLF
HZ~
IH2
IHE
J1W
K-O
KOM
L7B
LCYCR
LG5
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OQ.
OZT
P-8
P-9
P2P
PC.
PH~
Q38
R2-
RIG
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SSH
SSZ
T5K
UDS
UHS
UV1
WUQ
X7M
XPP
Z5R
ZGI
ZMT
ZU3
ZXP
~G-
08R
AAPBV
AAUGY
ABPIF
ABPTK
IQODW
AAXKI
AFJKZ
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c434t-339f91f98ba6c8d7c3201065adf8f5b35184a90cfd0c81c2fe76b8f515ba48a13
IEDL.DBID .~1
ISSN 0090-8258
IngestDate Thu Oct 24 23:51:34 EDT 2024
Thu Sep 26 18:58:56 EDT 2024
Sat Sep 28 07:36:30 EDT 2024
Sun Oct 29 17:08:46 EDT 2023
Fri Feb 23 02:26:03 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Human
Carcinoma
Prognosis
Stage classification
Malignant tumor
Metastasis
Female genital diseases
Lymphadenectomy
Pelvic ganglion
Surgery
Uterine diseases
Paraaortic ganglion
Endometrium
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c434t-339f91f98ba6c8d7c3201065adf8f5b35184a90cfd0c81c2fe76b8f515ba48a13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 9062142
PQID 78874751
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_78874751
crossref_primary_10_1006_gyno_1996_4573
pubmed_primary_9062142
pascalfrancis_primary_2606628
elsevier_sciencedirect_doi_10_1006_gyno_1996_4573
PublicationCentury 1900
PublicationDate 1997-03-01
PublicationDateYYYYMMDD 1997-03-01
PublicationDate_xml – month: 03
  year: 1997
  text: 1997-03-01
  day: 01
PublicationDecade 1990
PublicationPlace San Diego, CA
PublicationPlace_xml – name: San Diego, CA
– name: United States
PublicationTitle Gynecologic oncology
PublicationTitleAlternate Gynecol Oncol
PublicationYear 1997
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
SSID ssj0003012
Score 1.8989164
Snippet The purposes of this study were to analyze the relationship between retroperitoneal lymph node (RLN) metastasis and clinical and pathologic risk factors in...
SourceID proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 411
SubjectTerms Adult
Aged
Aorta, Abdominal
Biological and medical sciences
Endometrial Neoplasms - mortality
Endometrial Neoplasms - pathology
Endometrial Neoplasms - surgery
Female
Female genital diseases
Gynecology. Andrology. Obstetrics
Humans
Lymph Node Excision - methods
Lymphatic Metastasis
Medical sciences
Middle Aged
Multivariate Analysis
Prognosis
Retroperitoneal Neoplasms - mortality
Retroperitoneal Neoplasms - secondary
Retroperitoneal Neoplasms - surgery
Retrospective Studies
Risk Factors
Survival Rate
Tumors
Title Indispensability of Pelvic and Paraaortic Lymphadenectomy in Endometrial Cancers
URI https://dx.doi.org/10.1006/gyno.1996.4573
https://www.ncbi.nlm.nih.gov/pubmed/9062142
https://search.proquest.com/docview/78874751
Volume 64
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxsxEBYhhVAopa9Qt02iQ6Cnjb3WY6VjMAlO3ARTGpqbGO1KxdBoje0cfOlv78w-UnLwpaeFXYYV34xGI2nmG8ZOCx9F9L7KMJhXmTRSZaCUyHQwAjC8D7Y5zLm51dM7eX2v7vfYpK-FobTKzve3Pr3x1t2bYYfmcLlYUI0vtetWxmorVSGIE1Ti8oc2ffbnX5oHGnDLGN6UTCvTEzeO9PDXNtVUrafPSH7XwvRqCWuEK7Z9LnYHos2CdPmGve4iSX7eDvYt2wvpHTu46e7K37P5VaoW6yVuU1sq7i2vI5-H3-gaOKSKz2EFUJM0_7ZFnQJ6IDrCf9jyReIXqaofQtPTg0_IMlbrD-zu8uLHZJp1_ROyUgq5yYSw0ebRGg-6NFVRCrr61gqqaKLyQuHuDuyojNWoNHk5jqHQHr_kyoM0kItDtp_qFD4ybsGXuY6qjBgPxIjaFQBWyUICygg9YF978NyypclwLSGydgSzI5gdwTxgeY-te6Zohz58p8zRMyU8_WJM26-xGbCTXikOZwddeUAK9ePaUa6kLFQ-YIetrp5EiZ85l-NP_zGcz-xlS2JLmWhf2P5m9RiOMDTZ-OPG9o7Zi_Or2fSWnrPvP2d_AaRq5cY
link.rule.ids 315,783,787,4509,24128,27936,27937,45597,45691
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDCa6DtgGDMNexdKtqw4DdnITRw9LxyFokW5JkUML9CbQtjQEWOUgSQ-57LdXtOwOPeSyqw3KwkeaoiTyI8C3ovTcl2WdxWBeZkILmaGUPFNOc4zhvTPtYc78Sk1vxM9beXsAk74WhtIqO9-ffHrrrbsnww7N4Wq5pBpfatcttVFGyIKLZ_BcUHwcjfrs7788j2jBiTK8rZmWumduHKnh711oqFxPndEA-1am1yvcRLx8anSxPxJtV6SLt_CmCyXZjzTbd3Dgwnt4Me8uyz_A4jLUy80q7lMTF_eONZ4t3J_oGxiGmi1wjdiQNJvtolIxuiA6w7_bsWVg56Fu7lzb1INNyDTWm49wc3F-PZlmXQOFrBJcbDPOjTe5N7pEVem6qDjdfSuJtddellzG7R2aUeXrUaXzauxdocr4JpclCo05P4LD0AT3CZjBssqVl5WPAYH3Ub0c0UhRCIwyXA3gew-eXSWeDJsYkZUlmC3BbAnmAeQ9tvaJpm104ntlTp4o4fETY9p_jfUATnul2Ph70J0HBtfcbywlS4pC5gM4Srp6FCWC5lyMj_9jOqfwcno9n9nZ5dWvz_AqMdpSWtoXONyu791JjFO25dfWDh8A4uzlvA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Indispensability+of+pelvic+and+paraaortic+lymphadenectomy+in+endometrial+cancers&rft.jtitle=Gynecologic+oncology&rft.au=Yokoyama%2C+Y&rft.au=Maruyama%2C+H&rft.au=Sato%2C+S&rft.au=Saito%2C+Y&rft.date=1997-03-01&rft.issn=0090-8258&rft.volume=64&rft.issue=3&rft.spage=411&rft_id=info:doi/10.1006%2Fgyno.1996.4573&rft_id=info%3Apmid%2F9062142&rft.externalDocID=9062142
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0090-8258&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0090-8258&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0090-8258&client=summon